An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.
Vocalis Health announced the CE mark win Feb. 17, saying its VocalisCheck product can be accessed by smartphones and is intended to serve as an initial screening tool, not a definitive diagnostic tester.
The company says the system achieved good accuracy, 81%, in a recent clinical trial involving more than 2,000 people in India. The participants represented speakers of at least four languages.
Vocalis is working with Mayo Clinic on refining the software and expanding its applications for voice-based health screening.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.